Cargando…
HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling
Idiopathic pulmonary fibrosis is a chronic, progressive and lethal disease of unknown etiology that ranks among the most frequent interstitial lung diseases. Idiopathic pulmonary fibrosis is characterized by dysregulated healing mechanisms that lead to the accumulation of large amounts of collagen i...
Autores principales: | Tanguy, Julie, Boutanquoi, Pierre-Marie, Burgy, Olivier, Dondaine, Lucile, Beltramo, Guillaume, Uyanik, Burhan, Garrido, Carmen, Bonniaud, Philippe, Bellaye, Pierre-Simon, Goirand, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960643/ https://www.ncbi.nlm.nih.gov/pubmed/37259327 http://dx.doi.org/10.3390/ph16020177 |
Ejemplares similares
-
Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin
por: Burgy, Olivier, et al.
Publicado: (2016) -
Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases
por: Tanguy, Julie, et al.
Publicado: (2021) -
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis:
a matter of control
por: Bellaye, Pierre-Simon, et al.
Publicado: (2022) -
Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis
por: Burgy, Olivier, et al.
Publicado: (2022) -
[(18)F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [(18)F]FDG PET/CT approach
por: Tanguy, Julie, et al.
Publicado: (2021)